Together we will beat cancer

Donate

Drug improves survival of patients with rare cancer by almost a quarter

Patients who take capecitabine after surgery for bile duct cancer live for almost a year and a half longer than those not given the drug.

Read More

Trial results show dramatically improved survival for relapsed childhood leukaemia

A new treatment increases survival to almost 70 per cent for children whose acute lymphoblastic leukaemia (ALL) returns.

Read More